Descriptor English: | Temozolomide | ||||||
Descriptor Spanish: |
Temozolomida
| ||||||
Descriptor Portuguese: | Temozolomida | ||||||
Descriptor French: | Témozolomide | ||||||
Entry term(s): |
8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one CCRG 81045 CCRG-81045 CCRG81045 M&B 39831 M&B-39831 M&B39831 Methazolastone NSC 362856 NSC-362856 NSC362856 TMZ Bioshuttle TMZ-Bioshuttle TMZA-HE Temodal Temodar Temozolomide Hexyl Ester |
||||||
Tree number(s): |
D02.925.200.500 D03.383.129.308.240.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077204 | ||||||
Scope note: | A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents, Alkylating |
||||||
Registry Number: | YF1K15M17Y | ||||||
Public MeSH Note: | 2019; TEMOZOLOMIDE was indexed under DACARBAZINE 1989-2019, and under IMIDAZOLES 1985-1988 |
||||||
History Note: | 2019 (1985) |
||||||
DeCS ID: | 57539 | ||||||
Unique ID: | D000077204 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/01/11 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Temozolomide
- Preferred
Temodal
- Narrower
Temodar
- Broader
Temozolomide Hexyl Ester
- Narrower
CCRG 81045
- Narrower
TMZ-Bioshuttle
- Narrower
NSC 362856
- Narrower
M&B 39831
- Narrower
Concept UI |
M0136562 |
Scope note | A dacarbazine derivative that is used as an alkylating antineoplastic agent for the treatment of MALIGNANT GLIOMA and MALIGNANT MELANOMA. |
Preferred term | Temozolomide |
Entry term(s) |
8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one Methazolastone |
Concept UI |
M000624140 |
Preferred term | Temodal |
Concept UI |
M0414529 |
Preferred term | Temodar |
Concept UI |
M0514113 |
Preferred term | Temozolomide Hexyl Ester |
Entry term(s) |
TMZA-HE |
Concept UI |
M0136555 |
Preferred term | CCRG 81045 |
Entry term(s) |
CCRG-81045 CCRG81045 |
Concept UI |
M0543870 |
Preferred term | TMZ-Bioshuttle |
Entry term(s) |
TMZ Bioshuttle |
Concept UI |
M0136559 |
Preferred term | NSC 362856 |
Entry term(s) |
NSC-362856 NSC362856 |
Concept UI |
M0136557 |
Preferred term | M&B 39831 |
Entry term(s) |
M&B-39831 M&B39831 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey